Extrahepatic Bile Duct Adenocarcinoma
NCI Definition: An adenocarcinoma arising from the epithelium of the extrahepatic bile ducts. Signs and symptoms include abdominal pain, anorexia, jaundice, pruritus, nausea and vomiting, and weight loss. 
There are 2 clinical trials for extrahepatic bile duct adenocarcinoma, of which 1 is open and 1 is completed or closed. Of the trials that contain extrahepatic bile duct adenocarcinoma as an inclusion criterion, 1 is phase 1 (0 open) and 1 is phase 2 (1 open).
Cisplatin, gemcitabine, and pegph20 are the most common interventions in extrahepatic bile duct adenocarcinoma clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.